3-hydroxyflavone has been researched along with tricetin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bast, A; Brauers, K; Geraets, L; Haegens, A; Hageman, GJ; Haydock, JA; Vernooy, JH; Wouters, EF | 1 |
| Bast, A; Geraets, L; Hageman, GJ; Manders, RJ; Moonen, HJ; Pennings, HJ; van Loon, LJ; Weseler, AR; Wouters, EF | 1 |
2 other study(ies) available for 3-hydroxyflavone and tricetin
| Article | Year |
|---|---|
Inhibition of LPS-induced pulmonary inflammation by specific flavonoids.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chromones; Flavones; Flavonoids; Flavonols; Gene Expression; Heme Oxygenase-1; Inflammation Mediators; Interleukin-6; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Peroxidase; Pneumonia; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Superoxide Dismutase | 2009 |
Poly (ADP-ribose) polymerase-1-inhibiting flavonoids attenuate cytokine release in blood from male patients with chronic obstructive pulmonary disease or type 2 diabetes.
Topics: Aged; Chromones; Cytokines; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Flavonoids; Flavonols; Humans; Interleukin-1; Interleukin-10; Interleukin-8; Lipopolysaccharides; Male; Middle Aged; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Pulmonary Disease, Chronic Obstructive; Tumor Necrosis Factor-alpha | 2009 |